Parkwood LLC purchased a new stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 108,554 shares of the company’s stock, valued at approximately $5,492,000. Parkwood LLC owned 0.08% of Ionis Pharmaceuticals at the end of the most recent reporting […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $56.08 Average Price Target from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Releases Quarterly Earnings Results, Beats Expectations By $0.12 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Price Target Cut to $82.00 by Analysts at Wells Fargo & Company tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Releases Quarterly Earnings Results, Beats Estimates By $0.12 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.